ProstaGene
  • Home
  • News
  • About
    • Overview
    • Board of Directors
    • Management Team
    • Advisory Boards
      • Scientific Advisory Board
      • Clinical Advisory Board
      • Business Advisory Board
  • Careers
    • Overview
    • Benefits
    • Open Positions
  • R & D
  • Investors
  • Media
  • Contact Us
 
  • Home
  • /
  • News
  • /
  • ProstaGene assigned new patent in Prostate Cancer Diagnostics

ProstaGene assigned new patent in Prostate Cancer Diagnostics

Richard Pestell September 25, 2016

ProstaGene was assigned new patents in prostate cancer.

Issued Patent No. 2012225232, Title:  “Prostate Cancer Cell Lines, Gene Signatures And Uses Thereof“. Ref. 140993.00105 AU. issued August 25, 2016
http://patents.justia.com/inventor/richard-g-pestell

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Google+ (Opens in new window)

Related

Categories: News

Share this post on

« ProstaGene assigned new patents in cancer treatment
Richard Pestell »
My Tweets

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

Contact Us

ProstaGene LLC

100 Lancaster Avenue, Room 133, Wynnewood, PA 19096

prostagene@gmail.com

Copyright © 2015 Prostagene LLC. All Rights Reserved. | Powered by Seward Studios